The only health legislation that has a chance of passing before the elections this fall will be marked up by both chambers later this week, but key differences over proposed amendments to the FDA user fee bill in the House and Senate could lead to a protracted fight.
FDA bill up in the air over proposed changes
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.